CDK9 and familial pancreatic carcinoma: The Ub-like modifier activator enzyme E1 inhibitor TAK-981, in mice, reduced Ub-like modifier in pancreatic cancer cells in the nanomole range, resulting in G2/M cell cycle arrest and chromosome separation defects.